Book a demo
Skip to content

Stonewake Monitoring

Teva Pharmaceutical Industries files 8-K covering new debt obligation

Teva Pharmaceutical Industries Ltd submitted a 2026-09-16 8-K that includes debt-related disclosure items.

Export financeISRPublished · 2 sourced facts

Teva Pharmaceutical Industries Ltd, a pharmaceutical preparations company listed on the NYSE under the ticker TEVA, filed an 8-K with the SEC on 2026-09-16.[1][2]

The filing, recorded under accession number 0001193125-26-393116, covers items 1.01, 2.03, and 9.01 and is classified as a debt obligation filing dated 2026-09-16.[1]

The company trades under the tickers TEVA and TEVJF and files under CIK 0000818686, with the matched document being d155511d8k.htm and a period ending 2026-09-16.[1][2]

Sources

  1. [1]SEC EDGAR: 8-K, 0001193125-26-393116, 16 Sep 2026
  2. [2]SEC EDGAR: CIK 0000818686, TEVA PHARMACEUTICAL INDUSTRIES LTD

SEC EDGAR

← All briefs